Bee Venom and Prostate Cancer

Dr. Weeks’ Comment: PUB MED is a fabulous resource. Here we see current work with bee venom and prostate cancer. The real Sting!

Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids.

Gross S, AndrÃ¤ J.

Biol Chem. 2012 Aug;393(8):817-27. doi: 10.1515/hsz-2012-0136.

Related citations

Bee venom in cancer therapy.

OrÅ¡oliÄ‡ N.

Cancer Metastasis Rev. 2012 Jun;31(1-2):173-94. doi: 10.1007/s10555-011-9339-3. Review.

PMID:: Related citations

Select item 21456063

Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-ÎºB.

Park MH, Choi MS, Kwak DH, Oh KW, Yoon do Y, Han SB, Song HS, Song MJ, Hong JT.

Prostate. 2011 Jun 1;71(8):801-12. doi: 10.1002/pros.21296. Epub 2010 Nov 17.

PRelated citations

Select item 1941714

Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin.

LeBeau AM, Brennen WN, Aggarwal S, Denmeade SR.

Mol Cancer Ther. 2009 May;8(5):1378-86. doi: 10.1158/1535-7163.MCT-08-1170. Epub 2009 May 5.

EDLINE]

Free PMC Article

Related citations

Select item 18677401

Immune response to lytic peptides conjugated to a betaCG fragment in treated BALB/C mice.

Bogacki M, Enright FM, Todd WJ, Hansel W.

Reprod Biol. 2008 Jul;8(2):135-47.

Related citations

Select item 17555825

Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds.

Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT.

Pharmacol Ther. 2007 Aug;115(2):246-70. Epub 2007 May 6. Review

Related citations

Select item 17382461

Conjugates of lytic peptides and LHRH or betaCG target and cause necrosis of prostate cancers and metastases.

Hansel W, Leuschner C, Enright F.

Mol Cell Endocrinol. 2007 Apr 15;269(1-2):26-33. Epub 2007 Feb 15. Review.

PMID:: Related citations

Select item 16485125

Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate.

Putz T, Ramoner R, Gander H, Rahm A, Bartsch G, Thurnher M.

Cancer Immunol Immunother. 2006 Nov;55(11):1374-83. Epub 2006 Feb 17.

Related citations

Select item 16033998

Targeting breast and prostate cancers through their hormone receptors.

Leuschner C, Hansel W.

Biol Reprod. 2005 Nov;73(5):860-5. Epub 2005 Jul 20. Review.

Free Article

Related citations

Select item 15956772

10.

Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway.

Bodek G, Kowalczyk A, Waclawik A, Huhtaniemi I, Ziecik AJ.

Exp Biol Med (Maywood). 2005 Jun;230(6):421-8.

Related citations

Select item 14722669

11.

Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancerdirected antibody.

Carter T, Sterling-Levis K, Ow K, Doughty L, Hattarki M, Shapira D, Hewish D, Kortt AA, Russell PJ.

Cancer Immunol Immunother. 2004 Jun;53(6):533-42. Epub 2004 Jan 13.

Related citations

Select item 14722668

12.

Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies.

Russell PJ, Hewish D, Carter T, Sterling-Levis K, Ow K, Hattarki M, Doughty L, Guthrie R, Shapira D, Molloy PL, Werkmeister JA, Kortt AA.

Cancer Immunol Immunother. 2004 May;53(5):411-21. Epub 2004 Jan 13.

Related citations

Select item 12858351

13.

Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.

Leuschner C, Enright FM, Gawronska-Kozak B, Hansel W.

Prostate. 2003 Sep 1;56(4):239-49.

Related citations

Select item 12784188

14.

Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.

Zaleska M, Bodek G, Jana B, Hansel W, Ziecik AJ.

Exp Clin Endocrinol Diabetes. 2003 May;111(3):146-53.

Related citations

Select item 12611453

15.

Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breastcancer cells in vitro and in vivo.

Leuschner C, Enright FM, Gawronska B, Hansel W.

Breast Cancer Res Treat. 2003 Mar;78(1):17-27.

Related citations

Select item 12469190

16.

A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo.

Holle L, Song W, Holle E, Wei Y, Wagner T, Yu X.

Int J Oncol. 2003 Jan;22(1):93-8

Related citations

Select item 12021435

17.

Conformational and thermodynamic properties of peptide binding to the human S100P protein.

Gribenko AV, GuzmÃ¡n-Casado M, Lopez MM, Makhatadze GI.

Protein Sci. 2002 Jun;11(6):1367-75.

Free PMC Article

Related citations

Select item 11170139

18.

Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors.

Leuschner C, Enright FM, Melrose PA, Hansel W.

Prostate. 2001 Feb 1;46(2):116-25.

Related citations

Leave a Comment Cancel Reply